Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study.

about

Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study.

Item

http://www.wikidata.org/entity/Q55452535

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Absolute Insurer Denial of Dir ...... ecialty Pharmacy Cohort Study.

@en

Absolute Insurer Denial of Dir ...... ecialty Pharmacy Cohort Study.

@nl

type

Item

label

Absolute Insurer Denial of Dir ...... ecialty Pharmacy Cohort Study.

@en

Absolute Insurer Denial of Dir ...... ecialty Pharmacy Cohort Study.

@nl

prefLabel

Absolute Insurer Denial of Dir ...... ecialty Pharmacy Cohort Study.

@en

Absolute Insurer Denial of Dir ...... ecialty Pharmacy Cohort Study.

@nl

P1476

Absolute Insurer Denial of Dir ...... ecialty Pharmacy Cohort Study.

@en

P2093

Charitha Gowda

http://www.w3.org/2001/XMLSchema#string

Dena M Carbonari

http://www.w3.org/2001/XMLSchema#string

Jason A Roy

http://www.w3.org/2001/XMLSchema#string

Jay R Kostman

http://www.w3.org/2001/XMLSchema#string

M Elle Saine

http://www.w3.org/2001/XMLSchema#string

Matthew Grigorian

http://www.w3.org/2001/XMLSchema#string

Paul Urick

http://www.w3.org/2001/XMLSchema#string

Stacey Trooskin

http://www.w3.org/2001/XMLSchema#string

Stephen Lott

http://www.w3.org/2001/XMLSchema#string

Vincent Lo Re

http://www.w3.org/2001/XMLSchema#string

P2860

Access to treatment for hepatitis C virus infection: time to put patients first.

Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network.

Descriptive analyses of the integrity of a US Medicaid claims database.

Treatment of hepatitis C: a systematic review.

Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights.

Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance.

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England

Comparative Clinical Effectiveness and Value of Novel Interferon-Free Combination Therapy for Hepatitis C Genotype 1: Summary of California Technology Assessment Forum Report.

Access to Costly New Hepatitis C Drugs: Medicine, Money, and Advocacy.

The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection.

P304

ofy076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFY076

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29977955

http://www.w3.org/2001/XMLSchema#string

P932

6016397

http://www.w3.org/2001/XMLSchema#string